Arnold and Bar Or, McGill University (IMAGE)
Caption
Douglas Arnold, left, and Amit Bar-Or, right, were authors on three studies conducted by an international team of researchers that has shown a drug to reduce new attacks/symptom progression in some MS patients.
Credit
The Neuro
Usage Restrictions
None
License
Licensed content